Personalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Adverum Biotechnologiesadverum.com |
Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage biotechnology company developing Ixo-vec, an investigational AAV gene t | Redwood City, California | 51-200 | — |
REGENXBIOregenxbio.com |
REGENXBIO is a clinical-stage biotechnology company founded in 2008 and headquartered in Rockville, Maryland, pioneering AAV gene | Rockville, Maryland | 201-1000 | — |
uniQureuniqure.com C( |
uniQure is a gene therapy company with a modular, validated technology platform that advances a pipeline of proprietary and partne | Amsterdam, 1105BP | 201-1000 | — |
Pregenenbluebirdbio.com |
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, o | Seattle, Washington | 1-10 | — |
Crispagencrispagen.com |
— | — | — | |
Beam Therapeuticsbeamtx.com |
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a | Cambridge, Massachusetts | 201-1000 | — |
Nightstarxnightstarx.com |
— | — | — | |
Meirameira.com |
— | — | — | |
Genetherapysciencesgenetherapysciences.com |
— | — | — | |
Homologytxhomologytx.com |
— | — | — | |
4Dmtx4dmtx.com |
— | — | — | |
Logicbiologicbio.com |
— | — | — | |
Orchardtxorchardtx.com |
— | — | — | |
Beacontxbeacontx.com |
Beacon Therapeutics is a clinical-stage biotechnology company developing AAV gene therapy treatments to save and restore sight in | — | — | — |
Perseid Therapeuticsastellas.us |
Biotechnology | Bell Gardens, California | 5000+ | — |
Teamedon International,teamedon.com |
TeamedOn International, Inc. is a biotechnology company developing gene therapies for rare diseases, with a focus on ophthalmic in | Rockville, Maryland | 1-10 | — |
Coave Therapeuticscoavetx.com |
Coave Therapeutics is a clinical-stage biotechnology company developing targeted gene therapies for rare ocular and CNS diseases u | Paris, île-de-france | 51-200 | — |
Opus Geneticsopusgtx.com |
Opus Genetics is a clinical-stage biopharmaceutical company developing AAV-based gene therapies for inherited retinal diseases (IR | Raleigh, North Carolina | 11-50 | — |
Genentechgenentech.com |
— | — | — | |
Zebrazebra.com |
Zebra is a global provider of connected frontline, asset visibility, and automation solutions, with an award-winning portfolio spa | Lincolnshire, Illinois | 5000+ | — |
Robinhoodrobinhood.com |
Robinhood is a commission-free trading and investing platform that lets users trade stocks, options, crypto, and futures with frac | Menlo Park, California | 1001-5000 | — |
Editas Medicineeditasmedicine.com |
Editas Medicine is a clinical-stage genome editing company that develops CRISPR-based medicines for serious diseases, with a pipel | Cambridge, Massachusetts | 51-200 | — |
Sparktherapeuticssparktherapeutics.com |
— | — | — | |
Unique Mindsuniqueminds.com |
Unique Minds is a software development company founded in 2024 in Redmond, Washington, that integrates artificial intelligence to | Redmond, Washington | 1-10 | — |
Freshworksfreshworks.com |
Freshworks Inc. (NASDAQ: FRSH) builds unified service software for the AI era, offering enterprise-grade customer experience (CX) | San Mateo, California | 5000+ | — |
Coinbasecoinbase.com |
Coinbase is a digital currency wallet and trading platform founded in 2012 that lets users buy, sell, and trade cryptocurrencies l | Remote First, California | 5000+ | — |
Honeywellaidchoneywellaidc.com |
honeywellaidc.com is an unconfigured website template for a company named Honeywell, not a scraped business record. The domain res | — | 1001-5000 | — |
Crispatherapeuticscrispatherapeutics.com |
— | — | — | |
Intelliatxintelliatx.com |
Intellia Therapeutics is a clinical-stage biopharmaceutical company developing CRISPR-based gene editing therapies to treat severe | Cambridge, Massachusetts | 201-1000 | — |
Zendeskzendesk.com |
Zendesk is a B2B AI-powered customer service platform that helps companies manage customer interactions across support, sales, mar | — | — | — |
| Run live for more | ||||
Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage biotechnology company developing Ixo-vec, an investigational AAV gene therapy for wet age-related macular degeneration (wAMD) — a single-administration intravitreal treatment that converts retinal cells into ocular biofactories to produce aflibercept continuously, extending treatment benefit from weeks to years.
Companies like Adverum Biotechnologies include REGENXBIO, uniQure, Pregenen, Crispagen, Beam Therapeutics. See the full list of 24 competitors and alternatives above.
Adverum Biotechnologies has approximately 51-200 employees and is in the Biotechnology Research industry.
Adverum Biotechnologies is headquartered in Redwood City, California.
Adverum Biotechnologies operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Adverum Biotechnologies are listed above, including leaders across executive, finance, sales and operations.